Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. In addition to providing contract R&D and biologic manufacturing services for diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market, the company aims to continue to act as a trusted source for all researchers’ assay development and manufacturing needs.
- Creative Diagnostics à Creative Diagnostics
- Male
- 12/09/1994
- Suivi par 0 people
Mises à jour récentes
- Reliable Hemagglutination Assay for Virus and Antibody DetectionAs an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is proud to announce the launch of its Hemagglutination Assay (HA) services for effective virus and antibody detection. The new anti-virus testing solution offers a valuable tool for researchers working on influenza virus characterization, vaccine development, and general viral diagnostics....0 Commentaires 0 partsPlease log in to like, share and comment!
- Patulin Test Reagents for Food Safety ApplicationsCreative Diagnostics, a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for food, feed, environmental and toxicological sample analysis, announces the availability of its high-quality Patulin Test Reagents. These reagents are suitable for assisting food producers and regulatory agencies in ensuring the safety of apples and apple-derived...0 Commentaires 0 parts
- High-Affinity Anti-Adenovirus Monoclonal Antibodies for Research and Assay DevelopmentCreative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is pleased to announce the availability of its highly specific Anti-Adenovirus Monoclonal Antibody. This research tool offers exceptional accuracy and sensitivity for the detection of adenoviruses in various applications such as IF, ICC, and ELISA. Adenoviruses (members of the family Adenoviridae)...0 Commentaires 0 parts
Plus de lecture